{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:09:11Z","timestamp":1790964551249,"version":"4.1.0"},"reference-count":33,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,2,1]]},"DOI":"10.5551\/jat.65164","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T18:10:30Z","timestamp":1725387030000},"page":"253-264","source":"Crossref","is-referenced-by-count":9,"title":["Excess Triglycerides in Very Low-Density Lipoprotein (VLDL) Estimated from VLDL-Cholesterol could be a Useful Biomarker of Metabolic Dysfunction Associated Steatotic Liver Disease in Patients with Type 2 Diabetes"],"prefix":"10.5551","volume":"32","author":[{"given":"Tsutomu","family":"Hirano","sequence":"first","affiliation":[{"name":"Diabetes Center, Ebina General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-J\u00e4rvinen H, Fan JG, Gr\u00f8nb\u00e6k H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol, 2020; 73: 202-209","DOI":"10.1016\/j.jhep.2020.03.039"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Alomari M, Rashid MU, Chadalavada P, Ragheb J, Zafar H, Suarez ZK, Khazaaleh S, Gonzalez AJ, Castro FJ. Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes. World J Hepatol, 2023; 15: 477-496","DOI":"10.4254\/wjh.v15.i4.477"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med, 2010; 363: 1341-1350","DOI":"10.1056\/NEJMra0912063"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS. Nonalcoholic Fatty Liver Disease and the Heart. J Am Coll Cardiol, 2019; 73: 948-963","DOI":"10.1016\/j.jacc.2018.11.050"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res, 2016; 118: 547-563","DOI":"10.1161\/CIRCRESAHA.115.306249"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb, 1991; 11: 2-14","DOI":"10.1161\/01.ATV.11.1.2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Ikezaki H, Lim E, Cupples LA, Liu CT, Asztalos BF, Schaefer EJ. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study. J Am Heart Assoc, 2021; 10: e019140","DOI":"10.1161\/JAHA.120.019140"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hirano T, Satoh N, Ito Y. Specific Increase in Small Dense Low-Density Lipoprotein-Cholesterol Levels beyond Triglycerides in Patients with Diabetes: Implications for Cardiovascular Risk of MAFLD. J Atheroscler Thromb, 2024; 31: 36-47","DOI":"10.5551\/jat.64271"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Santos-Baez LS, Ginsberg HN. Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides. Curr Opin Lipidol, 2021; 32: 200-206","DOI":"10.1097\/MOL.0000000000000756"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hirano T. Pathophysiology of Diabetic Dyslipidemia. J Atheroscler Thromb, 2018; 25: 771-782","DOI":"10.5551\/jat.RV17023"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab, 2020; 42: 101092","DOI":"10.1016\/j.molmet.2020.101092"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res, 2002; 43: 1363-1379","DOI":"10.1194\/jlr.R200004-JLR200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bor\u00e9n J, Watts GF, Adiels M, S\u00f6derlund S, Chan DC, Hakkarainen A, Lundbom N, Matikainen N, Kahri J, Verg\u00e8s B, Barrett PH, Taskinen MR. Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study. Arterioscler Thromb Vasc Biol, 2015; 35: 2218-2224","DOI":"10.1161\/ATVBAHA.115.305614"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tilly-Kiesi M, Knudsen P, Groop L, Taskinen MR. Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group. J Lipid Res, 1996; 37: 1569-1578","DOI":"10.1016\/S0022-2275(20)39139-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Gill JM, Brown JC, Bedford D, Wright DM, Cooney J, Hughes DA, Packard CJ, Caslake MJ. Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects. Atherosclerosis, 2004; 176: 49-56","DOI":"10.1016\/j.atherosclerosis.2004.04.022"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J, Vehkavaara S, H\u00e4kkinen A, Olofsson SO, Yki-J\u00e4rvinen H, Bor\u00e9n J. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia, 2006; 49: 755-765","DOI":"10.1007\/s00125-005-0125-z"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Chen J, Fang Z, Luo Q, Wang X, Warda M, Das A, Oldoni F, Luo F. Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets. Lipids Health Dis, 2024; 23: 14","DOI":"10.1186\/s12944-023-01993-y"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Packard CJ, Shepherd J. (1997) Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol, 1997; 17: 3542-3556","DOI":"10.1161\/01.ATV.17.12.3542"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Malmstr\u00f6m R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-J\u00e4rvinen H, Shepherd J, Taskinen MR. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia, 1997; 40: 454-462","DOI":"10.1007\/s001250050700"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Lee J, Jang S, Jeong H, Ryu OH. Validation of the Friedewald formula for estimating low density lipoprotein cholesterol: the Korea National Health and Nutrition Examination Survey, 2009 to 2011. Korean J Intern Med, 2020; 35: 150-159","DOI":"10.3904\/kjim.2017.233"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA, 2013; 310: 2061-2068","DOI":"10.1001\/jama.2013.280532"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Narro GEC, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-G\u00f3mez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN; NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol, 2024; 29: 101133","DOI":"10.1097\/HEP.0000000000000520"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Hirano T, Satoh N, Kodera R, Hirashima T, Suzuki N, Aoki E, Oshima T, Hosoya M, Fujita M, Hayashi T, Ito Y. Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort. J Diabetes Investig, 2022; 13: 657-667","DOI":"10.1111\/jdi.13697"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ito Y, Fujimura M, Ohta M, Hirano T. Development of a homogeneous assay for measurement of small dense LDL cholesterol. Clin Chem, 2011; 57: 57-65","DOI":"10.1373\/clinchem.2010.149559"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ito Y, Ohta M, Ikezaki H, Machida A, Schaefer EJ, Furusyo N. Development and population results of a fully automated homogeneous assay for LDL triglyceride. J Appl Lab Med, 2018; 2: 746-756","DOI":"10.1373\/jalm.2017.024554"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Adiels M, Westerbacka J, Soro-Paavonen A, H\u00e4kkinen AM, Vehkavaara S, Caslake MJ, Packard C, Olofsson SO, Yki-J\u00e4rvinen H, Taskinen MR, Bor\u00e9n J. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia, 2007; 50: 2356-2365","DOI":"10.1007\/s00125-007-0790-1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) M\u00e4nnist\u00f6 VT, Simonen M, Soininen P, Tiainen M, Kangas AJ, Kaminska D et al. Lipoprotein subclass metabolism in nonalcoholic steatohepatitis. J Lipid Res, 2014; 55: 2676-2684","DOI":"10.1194\/jlr.P054387"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Bor\u00e9n J, Adiels M, Bj\u00f6rnson E, Matikainen N, S\u00f6derlund S, R\u00e4m\u00f6 J,et al. Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans. JCI Insight, 2020; 5: e144079","DOI":"10.1172\/jci.insight.144079"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Miller WG, Myers GL, Sakurabayashi I, Bachmann LM, Caudill SP, Dziekonski A, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem, 201056: 977-986","DOI":"10.1373\/clinchem.2009.142810"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Pietzsch J, Julius U, Nitzsche S, Hanefeld M. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance. Diabetes, 1998; 47: 1928-1934","DOI":"10.2337\/diabetes.47.12.1928"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Hiukka A, Fruchart-Najib J, Leinonen E, Hilden H, Fruchart JC, Taskinen MR. Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes. Diabetologia, 2005; 48: 1207-1215","DOI":"10.1007\/s00125-005-1753-z"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab, 2021; 50: 101238","DOI":"10.1016\/j.molmet.2021.101238"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/2\/32_65164\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:37:07Z","timestamp":1738366627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/2\/32_65164\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65164","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"article-number":"65164"}}